Clincosm LogoSign in Get a demo

Alzheimer's Disease

Showing 51 - 75 of 955
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mild Cognitive Impairment, Alzheimer's Disease Trial in Baltimore (grape seed polyphenolic extract, resveratrol)

Completed
  • Mild Cognitive Impairment
  • Alzheimer's Disease
  • grape seed polyphenolic extract, resveratrol
  • Baltimore, Maryland
    Johns Hopkins University
Jul 20, 2022

Alzheimer's Disease, Prodromal Alzheimer's Disease, Amyloid Plaque Trial in Liverpool, London (Placebo, ACI-24.060 at Dose A,

Recruiting
  • Alzheimer's Disease
  • +4 more
  • Placebo
  • +6 more
  • Liverpool, United Kingdom
  • +1 more
Jul 13, 2022

Alzheimer's Disease Trial in Roskilde (Light Therapy System (LTS): Active Setting, Light Therapy System (LTS): Sham Setting)

Not yet recruiting
  • Alzheimer's Disease
  • Light Therapy System (LTS): Active Setting
  • Light Therapy System (LTS): Sham Setting
  • Roskilde, Denmark
    Zealand University Hospital
Jun 27, 2022

Alzheimer's Disease Trial in White Plains (Benfotiamine)

Completed
Has Results
  • Alzheimer's Disease
  • White Plains, New York
    Burke
Jun 2, 2022

Alzheimer's Disease, Cognitive Impairment, Tauopathies Trial in Worldwide (ACI-35.030, Placebo, JACI-35.054)

Active, not recruiting
  • Alzheimer's Disease
  • +6 more
  • ACI-35.030
  • +2 more
  • Helsinki, Finland
  • +8 more
Jun 24, 2022

Mild Cognitive Impairment, Alzheimer's Disease Trial in New York, Troy (Lighting Intervention)

Recruiting
  • Mild Cognitive Impairment
  • Alzheimer's Disease
  • Lighting Intervention
  • New York, New York
  • +1 more
Jun 22, 2022

Alzheimer's Disease Trial in Toulouse (NanoLithium® NP03, Placebo)

Recruiting
  • Alzheimer's Disease
  • NanoLithium® NP03
  • Placebo
  • Toulouse, France
    CHU Toulouse - Hôpital La Grave - Cité de la Santé
Jun 14, 2022

Alzheimer's Disease Trial in Worldwide (Placebo, Gantenerumab)

Completed
Has Results
  • Alzheimer's Disease
  • Sun City, Arizona
  • +130 more
May 23, 2022

Alzheimer's Disease Trial in Beachwood (Isotretinoin)

Terminated
Has Results
  • Alzheimer's Disease
  • Beachwood, Ohio
    Parkway Medical Building
May 20, 2022

Alzheimer's Disease Trial in United States (TB006, Placebo)

Active, not recruiting
  • Alzheimer's Disease
  • Garden Grove, California
  • +17 more
May 29, 2022

Dementia, Alzheimer's Disease, Dementia Prevention Trial in La Jolla (HALT-AD)

Active, not recruiting
  • Dementia
  • +2 more
  • HALT-AD
  • La Jolla, California
    Alzheimer's Disease Cooperative Study (ADCS)
May 25, 2022

Alzheimer's Disease Trial in United States (MK-1942, Donepezil, Placebo)

Completed
  • Alzheimer's Disease
  • Rogers, Arkansas
  • +3 more
May 24, 2022

Alzheimer's Disease Trial in San Francisco, Minneapolis (levetiracetam)

Completed
Has Results
  • Alzheimer's Disease
  • San Francisco, California
  • +1 more
Apr 22, 2022

Alzheimer's Disease Trial in Worldwide (Aducanumab)

Active, not recruiting
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +296 more
May 12, 2022

Dementia, Alzheimer's Disease, Frontotemporal Dementia Trial in United States (In-home technology, Limited in-home technology)

Completed
Has Results
  • Dementia
  • +2 more
  • In-home technology
  • Limited in-home technology
  • Berkeley, California
  • +4 more
Apr 14, 2022

Alzheimer's Disease Trial in Montréal (Eye-Tracking)

Recruiting
  • Alzheimer's Disease
  • Eye-Tracking
  • Montréal, Quebec, Canada
    The Douglas Research Centre
May 3, 2022

Alzheimer's Disease Trial in Canada (Perindopril, Telmisartan)

Recruiting
  • Alzheimer's Disease
  • Calgary, Alberta, Canada
  • +9 more
May 3, 2022

Alzheimer's Disease Trial in Gilbert, Palmetto Bay, Papillion (simufilam)

Enrolling by invitation
  • Alzheimer's Disease
  • Gilbert, Arizona
  • +2 more
Apr 26, 2022

CNS Tau Kinetics in Healthy Aging and Alzheimer's Disease

Recruiting
  • Alzheimer's Disease
  • +8 more
  • L-Leucine 13C6
  • Saint Louis, Missouri
    Washington University in Saint Louis
Apr 12, 2022

Mild Cognitive Impairment, Alzheimer's Disease Trial in Australia (Xanamem® 5 mg, Placebo, Xanamem® 10 mg)

Completed
  • Mild Cognitive Impairment
  • Alzheimer's Disease
  • Xanamem® 5 mg
  • +2 more
  • Bruce, Australian Capital Territory, Australia
  • +4 more
Apr 6, 2022

Alzheimer's Disease, Aging Trial in Madison (Enhanced Physical Activity)

Completed
Has Results
  • Alzheimer's Disease
  • Aging
  • Enhanced Physical Activity
  • Madison, Wisconsin
    University of Wisconsin School of Medicine and Public Health
Apr 1, 2022

Effect of REST in the Alzheimer Disease Continuum

Completed
  • Alzheimer's Disease
    • Beijing, Beijing, China
      Dongzhimen Hospital,Beijing University of Chinese Medicine
    Mar 22, 2022

    Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Birmingham, Alabama
    • +132 more
    Feb 16, 2022

    Alzheimer's Disease Trial (Piromelatine 20 mg, Placebo)

    Not yet recruiting
    • Alzheimer's Disease
    • Piromelatine 20 mg
    • Placebo
    • (no location specified)
    Mar 3, 2022

    Disease Progression Using Deep Neuro Signatures

    Recruiting
    • Alzheimer's Disease
    • Mild Cognitive Impairment
      • Athens, Greece
        Nikaia Ag Panteleimon Hospital
      Feb 10, 2022